Mereo BioPharma Group plc
MREO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $433,294 | $352,926 | $543,010 |
| - Cash | $48,698 | $56,125 | $62,483 | $69,802 |
| + Debt | $0 | $601 | $747 | $6,429 |
| Enterprise Value | – | $377,770 | $291,190 | $479,637 |
| Revenue | $0 | $500 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$1 | $368 | $0 | -$271 |
| % Margin | – | 73.6% | – | – |
| EBITDA | -$9,815 | -$14,294 | -$12,437 | -$6,908 |
| % Margin | – | -2,858.8% | – | – |
| Net Income | -$7,024 | -$14,616 | -$12,887 | -$6,981 |
| % Margin | – | -2,923.2% | – | – |
| EPS Diluted | -0.05 | -0.093 | -0.082 | -0.045 |
| % Growth | 45.9% | -12.8% | -82.2% | – |
| Operating Cash Flow | -$7,309 | -$7,651 | -$8,329 | -$9,420 |
| Capital Expenditures | $0 | $0 | -$320 | $0 |
| Free Cash Flow | -$7,309 | -$7,651 | -$8,649 | -$9,420 |